These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 9293792

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
    Fiebrich HB, Brouwers AH, Koopmans KP, de Vries EG.
    Eur J Cancer; 2009 Sep; 45(13):2312-5. PubMed ID: 19477116
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y, Bar-Ziv J, de Jong RB, Ish-Shalom S, Chisin R, Shibley N, Glaser B.
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [Abstract] [Full Text] [Related]

  • 6. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
    Takahashi H, Yamaguchi K, Wakui A, Maeda S, Yang PK, Ito M, Matsuzawa T, Fukuda H, Ido T.
    Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 'False-positive' uptake of FDG in a hepatic adenoma.
    Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G.
    Clin Nucl Med; 1997 Jul; 22(7):490-1. PubMed ID: 9227877
    [No Abstract] [Full Text] [Related]

  • 9. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
    Vitola JV, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright JK, Chapman WC, Pinson CW.
    Am J Surg; 1996 Jan; 171(1):21-6. PubMed ID: 8554144
    [Abstract] [Full Text] [Related]

  • 10. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
    Yonekura Y, Benua RS, Brill AB, Som P, Yeh SD, Kemeny NE, Fowler JS, MacGregor RR, Stamm R, Christman DR, Wolf AP.
    J Nucl Med; 1982 Dec; 23(12):1133-7. PubMed ID: 6982967
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
    Avram AM, Mackie GC, Schneider BJ, Kalemkerian GP, Shulkin BL.
    Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
    [Abstract] [Full Text] [Related]

  • 14. Functional imaging of malignant paragangliomas and carcinoid tumours.
    Le Rest C, Bomanji JB, Costa DC, Townsend CE, Visvikis D, Ell PJ.
    Eur J Nucl Med; 2001 Apr; 28(4):478-82. PubMed ID: 11357498
    [Abstract] [Full Text] [Related]

  • 15. [Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors].
    Banzo J, Prats E, Razola P, García S, Alonso V, Velilla J, Freile E, Benito JL, García F, Ubieto MA, Tardín L, Abós MD.
    Rev Esp Med Nucl; 2005 Apr; 24(4):278-92. PubMed ID: 16122413
    [No Abstract] [Full Text] [Related]

  • 16. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
    Fujishita T, Kishida M, Taki H, Shinoda C, Miyabayashi K, Fujishita M, Maruyama M, Mizushima Y, Kobayashi M.
    Respirology; 2007 Nov; 12(6):928-30. PubMed ID: 17986127
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
    Kurtaran A, Raderer M, Müller C, Prokesch R, Kaserer K, Eibenberger K, Koperna K, Niederle B, Virgolini I.
    J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET].
    Okazumi S, Enomoto K, Ozaki M, Yamamoto H, Yoshida M, Abe Y, Takayama W, Yamada S, Isono K, Imazeki K.
    Kaku Igaku; 1989 Jun; 26(6):793-7. PubMed ID: 2796006
    [Abstract] [Full Text] [Related]

  • 19. Bronchopulmonary carcinoid tumor and related cervical vertebral metastasis with PET-positive and octreotide-negative scintigraphy.
    Nguyen BD, Ram PC.
    Clin Nucl Med; 2006 Feb; 31(2):101-3. PubMed ID: 16424699
    [No Abstract] [Full Text] [Related]

  • 20. 18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor.
    Acevedo-Báñez I, Tirado-Hospital JL, Muñiz-Grijalvo O, Mangas-Cruz MA, García-Gómez FJ.
    Endocrinol Nutr; 2015 Apr; 62(4):202-4. PubMed ID: 25726370
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.